Dataset from Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNFα) Therapy
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00010134
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate guselkumab efficacy versus placebo in participants
with active psoriatic arthritis (PsA) and an inadequate response to Anti-Tumor Necrosis
Factor Alpha (TNF-alpha) therapy by assessing the reduction in signs and symptoms of joint
disease.
创建时间：
2025-02-10
